ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Saxagliptin Impurity 34
Saxagliptin Impurity 34
- CAS No.
- 2173146-31-9
- Chemical Name:
- Saxagliptin Impurity 34
- Synonyms
- Saxagliptin Impurity 34;Saxagliptin Impurity 57;(S)-2-((tert-Butoxycarbonyl)amino)-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetic Acid;(αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-oxotricyclo[3.3.1.13,7]decane-1-acetic Acid;Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-4-oxo-, (αS)-;(alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-oxotricyclo[3.3.1.13,7]decane-1-acetic Acid
- CBNumber:
- CB64819570
- Molecular Formula:
- C17H25NO5
- Molecular Weight:
- 323.39
- MOL File:
- 2173146-31-9.mol
Saxagliptin Impurity 34 Preparation Products And Raw materials
Raw materials
Preparation Products
Saxagliptin Impurity 34 Suppliers
Global( 13)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
| China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
| Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
| QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | China | 18865 | 58 | Inquiry |
| Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 | China | 9911 | 50 | Inquiry |
| Nanjing XiZe Biotechnology CO., Ltd. | 025-58362220 15250997978 | China | 7774 | 55 | Inquiry |
| HX Pharmaceutical technology co., LTD | 15671363360 | China | 2808 | 58 | Inquiry |
| Scinova Biotech(Guangzhou) Co., Ltd. | 13268215580 | China | 7026 | 58 | Inquiry |
| SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD | 0755-0755-0755-83725350 13380397412 | China | 10071 | 58 | Inquiry |
2173146-31-9(Saxagliptin Impurity 34)Related Search:
3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one, 6-aMino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
Saxagliptin Impurity 15
Saxagliptin Impurity 16
(1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
(1S,3S,5S)-2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-
Saxagliptin
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
1H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione, hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)-
(R)-N-Boc-3-hydroxyadaMantylglycine
1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-
Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-diMethylethoxy)carbonyl]aMino]-3,5-dihydroxy-, (αS)-
chevron_left
1of4
chevron_right
(αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-oxotricyclo[3.3.1.13,7]decane-1-acetic Acid
Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-4-oxo-, (αS)-
Saxagliptin Impurity 57
(S)-2-((tert-Butoxycarbonyl)amino)-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetic Acid
(alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-oxotricyclo[3.3.1.13,7]decane-1-acetic Acid
Saxagliptin Impurity 34
2173146-31-9